glp 1 and addiction Not just obesity: GLP-1 receptor agonists advance on Frontiers | The therapeutic potential

Could GLP1 WeightLoss Drugs Help Tackle Alzheimers Disease

Front Endocrinol (Lausanne) 2023;14:1215356

In a complex adaptive system like the human body, function depends on relationships among parts: muscle, fat, liver health, strength, mobility, and physical demand

While not officially listed as a common side effect, this "emotional blunting" is part of how the drugs can lead to reduced food noise, as well as reduced alcohol or other drug urges, but at the same time may also result in diminished enjoyment in hobbies, competitive drive, even for some people loss of interest in exercising, as well as people describing a "loss of empathy" - though I also see it said that it is a temporary experience for some people

You cannot simply take Akkermansia alone and expect the same results

the large share of the market is mainly due to supportive regulatory frameworks, escalating investments in R&D, and a rising prevalence of chronic diseases